Form 4 for COR Cencora
Accepted 2021-07-21 00:00:00 ET · period of report 2021-07-20 · accession 0001127602-21-022334 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-07-21 | 2021-07-20 | COR | COLLIS STEVEN H | COB, Pres, CEO, Dir | M - OptEx | $98.24 | +12.8K | 199.6K | +7% | +$1.26M |
| D | 2021-07-21 | 2021-07-20 | COR | COLLIS STEVEN H | COB, Pres, CEO, Dir | S - Sale+OE | $117.66 | -12.8K | 186.8K | -6% | -$1.50M |
| D | 2021-07-21 | 2021-07-20 | COR | COLLIS STEVEN H | COB, Pres, CEO, Dir | M - OptEx | $0.00 | -12.8K | 89.5K | -13% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-20 | M | A | 12,784 | $98.24 | 199,609 | D | — | — | (F1) The sale of stock reflected in this Form 4 was affected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective February 12, 2021 and disclosed in the Company's 8-K filed with the Securities and Exchange Commission on February 18, 2021. |
| 2 | Common | Common Stock | 2021-07-20 | S | D | 12,784 | $117.66 | 186,825 | D | — | — | (F1) The sale of stock reflected in this Form 4 was affected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective February 12, 2021 and disclosed in the Company's 8-K filed with the Securities and Exchange Commission on February 18, 2021. |
| 3 | Derivative | Non-qualified Stock Option (Right to Buy) | 2021-07-20 | M | D | 12,784 | $0.00 | 89,487 | D | $98.24 · — to 2022-11-11 | 12,784 Common Stock | (F1) The sale of stock reflected in this Form 4 was affected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective February 12, 2021 and disclosed in the Company's 8-K filed with the Securities and Exchange Commission on February 18, 2021. (F2) Exerciseable in four equal annual installments on 11/11/16, 11/11/17, 11/11/18 and 11/11/19. |